Higher Medicaid Reimbursement Ups Appointment Availability

This article originally appeared here.
Share this content:
Higher Medicaid Reimbursement Ups Appointment Availability
Higher Medicaid Reimbursement Ups Appointment Availability

(HealthDay News) -- Increased Medicaid reimbursement to primary care providers is associated with improved appointment availability, according to a study published online Jan. 21 in the New England Journal of Medicine.

Daniel Polsky, Ph.D., from the Perelman School of Medicine in Philadelphia, and colleagues measured the availability of and waiting times for appointments in 10 states during two periods from November 2012 through March 2013 and from May 2014 through July 2014. Trained field staff posed as Medicaid or privately insured enrollees seeking primary care appointments for new patients. The authors examined state-level changes over time in a stable cohort of primary care practices that participated in Medicaid.

The researchers found that between the two time periods there was a 7.7 percent increase in the availability of primary care appointments, from 58.7 to 66.4 percent. The largest increases in availability tended to be in states with the largest increases in reimbursements, with an estimated 1.25 percent increase in availability per 10 percent increase in Medicaid reimbursements (P = 0.03). In the private insurance group there was no such association observed. In the two study groups, waiting times for a scheduled new-patient appointment remained stable over time.

"Our study provides early evidence that increased Medicaid reimbursement to primary care providers, as mandated in the Affordable Care Act, was associated with improved appointment availability for Medicaid enrollees among participating providers without generating longer waiting times," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »